George Magrath - Nov 1, 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Signature
/s/ Stephanie Swan , by Power of Attorney
Stock symbol
OCUP
Transactions as of
Nov 1, 2023
Transactions value $
$0
Form type
4
Date filed
11/3/2023, 09:29 AM
Next filing
Mar 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Award $0 +400K $0.00 400K Nov 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Employee Stock Option (right to buy) Award $0 +600K $0.00 600K Nov 1, 2023 Common Stock 600K $2.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of November 1, 2023.
F2 The option will vest with respect to 25% on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments on the last day of each full month over the subsequent 36 months, subject to continuing service.